 |
|
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Products Name: | Azaperone | CAS: | 1649-18-9 |
|---|---|---|---|
| MF: | C19H22FN3O | MW: | MW： |
| Purity: | 99% | Color: | White Powder |
| High Light: | Azaperone Pharma Raw Material,1649-18-9 Pharma Raw Material |
||
Azaperone Anti-anxiety depression CAS: 1649-18-9 Best Quality Dissolved in water
Quick Detail:
Product Name: Azaperone
English name: AZAPERONE; Azaperone (200 mg); NSC 170976; Azaperone 1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone; AZAPERON; AZAPERONE; 1-( 4-FLUOROPHENYL)-4-[4-(2-PYRIDINYL)-1-PIPERAZINYL]-1-BUTANONE; 1-(4-FLUORO-PHENYL)-4-(4-PYRIDIN-2-YL-PIPERAZIN-1- YL)-BUTAN-1-ONE; 1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine
MF: C19H22FN3O
MW: 327.4
CAS: 1649-18-9
Standard: Enterprise Standard
Level: General level
Content: 99%
Appearance: white powder
Packing: 1KG can not be sold domestically / aluminum foil bag
Physical and chemical properties: white or off-white crystalline powder
Category: Chemical raw materials
What Is Azaperone:
Azaperone is a licensed and commonly used pig sedative in Europe and is available for use in wildlife in the USA. Azaperone must be given by deep IM injection and the pig should be left undisturbed for 20 minutes for best effect. The dose range is 1–8 mg/kg depending on the effects sought, but it is recommended that a dose of 1 mg/kg is not exceeded for adult boars as higher doses can cause prolapse of the penis.
Azaperone causes vasodilation resulting in a small fall in arterial blood pressure, and some slight respiratory stimulation. Hypothermia may develop in sedated pigs in a cold environment.Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with sedative and antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.
Azaperone COA:
| Catalog Num | A16416 |
|---|---|
| Actions | Antagonist |
| M. Wt | 327.4 |
| Formula | C19H22FN3O |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1649-18-9 |
| Synonyms | NSC 170976 |
| SMILES | C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3 |
Azaperone Description:
Azaperone tartrate produces predictable psychomotor sedation without narcosis after intramuscular administration. It was developed for approval in domestic swine because of its pronounced sedative action, good tolerance and wide safety margin. Anti-shock activity of azaperone is 60 times higher than that of propionylpromazine and its adrenalytic action is 20 times lower.
Azaperone tartrate has the chemical structure of 4’-fluoro-[4-(2-pyridyl)-1- piperazinyl]-butyrophenone. It is light sensitive and should be protected from light and heat. In solution, its pH is approximately 4.
Azaperone is rapidly absorbed from the injection site with peak concentrations in plasma occurring within one hour after administration. Elimination from plasma is ½-2.5 hr. due to rapid and extensive metabolism. Metabolic pathways are 1) reduction of the butanone 2) oxidative N-dearylation 3) hydroxylation of the pyridine group. The target tissue for azaperone and its metabolites is the liver. Low residue levels are present in muscle and other edible tissues.
Contact Person: Sales Manager
Tel: +8613429837396
